Personalized Repetitive Transcranial Magnetic Stimulation to Improve Walking in Parkinsons Disease Patients Aged 50 and Older
Led by Samsung Medical Center · Updated on 2026-04-28
60
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are investigating the effects of different repetitive transcranial magnetic stimulation rTMS therapy protocols tailored to the functional reserve of patients with Parkinsons disease. The study compares these personalized protocols with the conventional high-frequency rTMS therapy applied to the bilateral primary motor cortex M1. The goal is to see if customizing the stimulation based on motor or cognitive functional reserve leads to better motor function recovery and ambulatory improvement in people with Parkinsons disease.
Participants are first assessed using the Timed Up and Go Test TUG and Timed Up and Go Dual Task-Cognitive TUG-Cog to classify them as having either motor or cognitive priority functional reserve. Based on this, they are randomly assigned to one of four groups motor priority patients receive either high-frequency rTMS over the more affected primary motor cortex or bilateral M1 of the lower extremities, while cognitive priority patients receive high-frequency rTMS over the left dorsolateral prefrontal cortex DLPFC or bilateral M1. Each participant undergoes 20 sessions of 10-Hz rTMS at 90% resting motor threshold, five days a week for four weeks, followed by treadmill gait training and routine Parkinsons disease pharmacotherapy.
Throughout the study, participants mobility and motor functions are evaluated using various tests including the Timed Up and Go Test TUG, TUG-Cog, Movement Disorder Society-Unified Parkinsons Disease Rating Scale MDS-UPDRS, and Freezing of Gait Questionnaire FoG-Q. Additional assessments involve cognitive tests like the Digit Span Test and Trail Making Test, as well as gait lab parameters such as speed, stride length, and pressure distribution. These measures are taken at baseline, during intervention, post-intervention, and two months after to monitor changes. Safety, efficacy, and the impact on ambulatory function are carefully tracked over the study period.
CONDITIONS
Brief Title
Personalized rTMS Protocol Based on Functional Reserve to Enhance Ambulatory Function in PD Patients
Research Team
W
Won Hyuk Chang, PhD
H
Ho Seok Lee, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Diagnosed with Parkinson's disease by UK Parkinson's Disease Society Brain Bank Diagnostic Criteria
Modified Hoehn and Yahr (H&Y) scale stage 2 to 4
Able to walk on flat surfaces without a gait aid
Aged 50 years or older
Willing to sign informed consent
You will not qualify if you...
Contraindications to rTMS such as epilepsy, metal implants in the head, or history of craniotomy
Cognitive impairment based on Montreal Cognitive Assessment (MoCA) below education-adjusted thresholds
Coexisting neurological conditions like spinal cord injury or stroke
Major psychiatric disorders including major depression, schizophrenia, or dementia
Severe on-off phenomena or dyskinesia making study participation unsuitable
Contraindications to MRI
Pregnant or breastfeeding
Refusal to participate in the study
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Implementation
Duration - 4 weeks
Participants receive personalized repetitive transcranial magnetic stimulation (rTMS) targeting specific brain areas based on their functional reserve. The intervention includes 10 sessions over 4 weeks, combined with treadmill gait training and routine Parkinson's disease pharmacotherapy.
10 daily visits over 4 weeks (5 days per 2 weeks)
Follow-up
Duration - 2 months
Participants are monitored for continued effects and safety after completing the rTMS intervention.
Assessments at 2 months post-intervention
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Similar Trials
Comparing Two Deep Brain Stimulation Settings for Parkinsons Disease
Focusing on Postural Instability and Gait Disorder
Using Neurostimulator Pathway Activation Optimization
Study of Blood Flow Restriction with Balance Strengthening Exercises to Improve Symptoms in Parkinsons Disease
Evaluating the Effectiveness and Brain Mechanism of tDCS Treatment for Swallowing Problems in Parkinsons Disease
Studying Colon Tissue Samples During Routine Colonoscopy to Detect Parkinsons Disease Early
Study of Deep Brain Stimulation Effects on Memory and Cognition in Parkinsons Disease Patients Aged 50 to 70
PETCT Imaging Using 18F-FPyCOSMBT-1 to Diagnose Parkinsons Disease and Related Conditions
Study of Deep Brain Stimulation Effects on Sleep Problems in Parkinsons Disease Patients Using Wearable Sleep Monitoring
NYSCF Biobank Study Using Stem Cells and Genetic Testing to Research Diseases and Traits
Personalized Repetitive Transcranial Magnetic Stimulation to Improve Walking in Parkinsons Disease Patients Aged 50 and Older
Effects of Percept RC Deep Brain Stimulation on Sleep Quality in Parkinsons Disease Using Overnight Polysomnography
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Efficacy of personalized repetitive transcranial magnetic stimulation based on functional reserve to enhance ambulatory function in patients with Parkinson's disease: study protocol for a randomized controlled trial.